{"id":2188,"date":"2024-04-19T17:01:33","date_gmt":"2024-04-19T17:01:33","guid":{"rendered":"https:\/\/www.slovhep.sk\/verejnost\/clanok?uid=c079fc234628468dab7354b65031c794"},"modified":"2024-04-19T17:01:33","modified_gmt":"2024-04-19T17:01:33","slug":"verejnost-c079fc234628468dab7354b65031c794","status":"publish","type":"post","link":"https:\/\/slovhep.sk\/en\/verejnost-c079fc234628468dab7354b65031c794","title":{"rendered":"Liver Aim"},"content":{"rendered":"<p><img decoding=\"async\" src=\"\/wp-content\/uploads\/slovhep-media\/Slide1-d0bb37126e.png\" width=\"700\" \/><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><em>Ochorenia pe\u010dene s&uacute; v Eur&oacute;pe ka\u017edoro\u010dne pr&iacute;\u010dinou 300 000 &uacute;mrt&iacute;.<\/em> <em>Spolupr&aacute;ca v&yacute;skumn&iacute;kov, biotechnologick&yacute;ch spolo\u010dnost&iacute; a farmaceutick&eacute;ho priemyslu sa s podporou iniciat&iacute;vy Innovative Health Initiative sna\u017e&iacute; zlep&scaron;i\u0165 \u017eivot a zdravie \u013eud&iacute; so skryt&yacute;mi ochoreniami pe\u010dene uskuto\u010dnen&iacute;m doteraz najv&auml;\u010d&scaron;ej &scaron;t&uacute;die o v\u010dasnom odhalen&iacute; po&scaron;kodenia pe\u010dene.<\/em><\/p>\n<p>Cirh&oacute;za a rakovina pe\u010dene predstavuj&uacute; zna\u010dn&uacute; z&aacute;\u0165a\u017e pre syst&eacute;my zdravotnej starostlivosti, ovplyv\u0148uj&uacute; kvalitu \u017eivota, produktivitu pr&aacute;ce a vy\u017eaduj&uacute; si &scaron;pecializovan&uacute; lek&aacute;rsku starostlivos\u0165. Medzi k\u013e&uacute;\u010dov&eacute; rizikov&eacute; faktory cirh&oacute;zy aj rakoviny patr&iacute; obezita, cukrovka 2. typu a zv&yacute;&scaron;en&aacute; konzum&aacute;cia alkoholu &#8211; trendy, ktor&eacute; s&uacute; na vzostupe v celej Eur&oacute;pe aj vo svete. Bohu\u017eia\u013e, tieto ochorenia \u010dasto prebiehaj&uacute; v tichosti, a\u017e k&yacute;m sa neobjavia z&aacute;va\u017en&eacute; pr&iacute;znaky a komplik&aacute;cie. Transplant&aacute;cia pe\u010dene je s&iacute;ce &uacute;\u010dinnou lie\u010dbou, ale nie je v&scaron;eobecne dostupn&aacute;.<\/p>\n<p>Ak sa v&scaron;ak ochorenie pe\u010dene odhal&iacute; v\u010das, v &scaron;t&aacute;diu fibr&oacute;zy, je mo\u017en&eacute; <strong>zvr&aacute;ti\u0165<\/strong> z&aacute;va\u017en&eacute; n&aacute;sledky <strong>a pred&iacute;s\u0165<\/strong> im. Vst&uacute;pte do <strong>projektu LIVERAIM<\/strong>: spolupr&aacute;ca renomovan&yacute;ch klinick&yacute;ch centier a priemyseln&yacute;ch partnerov vr&aacute;tane mal&yacute;ch a stredn&yacute;ch podnikov s odborn&yacute;mi znalos\u0165ami v oblasti ochoren&iacute; pe\u010dene. Ich cie\u013eom je navrhn&uacute;\u0165 a overi\u0165 <strong>skr&iacute;ningov&uacute; platformu s<\/strong> biomarkermi na celopopula\u010dn&eacute; pou\u017eitie v Eur&oacute;pe. Cie\u013e? <strong>V\u010dasn&aacute; identifik&aacute;cia ochorenia pe\u010dene<\/strong> a personalizovan&eacute; terapeutick&eacute; z&aacute;sahy.<\/p>\n<p>Tu sa dozviete, ako <strong>LIVERAIM<\/strong> funguje:<\/p>\n<p>&nbsp;<\/p>\n<ol>\n<li><strong>Testovanie biomarkerov<\/strong>: Existuj&uacute;ce biomarkery sa bud&uacute; hodnoti\u0165 z h\u013eadiska ich presnosti pri predpovedan&iacute; fibr&oacute;zy. T&aacute;to anal&yacute;za bude zah\u0155\u0148a\u0165 <strong>30 000 vzoriek plazmy<\/strong> z kohort financovan&yacute;ch v r&aacute;mci H2020 E&Uacute;.<\/li>\n<li><strong>Skr&iacute;ningov&aacute; platforma na b&aacute;ze umelej inteligencie<\/strong>: Pomocou umelej inteligencie (AI) partneri vyvin&uacute; skr&iacute;ningov&uacute; platformu na <strong>personalizovan&uacute; v\u010dasn&uacute; diagnostiku fibr&oacute;zy pe\u010dene<\/strong>.<\/li>\n<li><strong>Valid&aacute;cia<\/strong>: Platforma bude d&ocirc;sledne overen&aacute; v randomizovanej kontrolovanej &scaron;t&uacute;dii (RCT), ktor&aacute; bude zah\u0155\u0148a\u0165 <strong>100 000 subjektov<\/strong> zo &scaron;iestich reprezentat&iacute;vnych kraj&iacute;n E&Uacute;.<\/li>\n<li><strong>Intervencie &scaron;it&eacute; na mieru<\/strong>: Platforma bude prepojen&aacute; s personalizovan&yacute;mi terapeutick&yacute;mi intervenciami zameran&yacute;mi na <strong>zastavenie progresie fibr&oacute;zy<\/strong>.<\/li>\n<\/ol>\n<p>Umo\u017enen&iacute;m v\u010dasnej diagnostiky a personalizovan&yacute;ch intervenci&iacute; m&aacute; <strong>LIVERAIM<\/strong> za cie\u013e zn&iacute;\u017ei\u0165 chorobnos\u0165, &uacute;mrtnos\u0165 a s&uacute;visiace ekonomick&eacute; a zdravotn&eacute; nerovnosti s&uacute;visiace s ochoren&iacute;m pe\u010dene.<\/p>\n<p><em>Tento projekt je podporovan&yacute; spolo\u010dn&yacute;m podnikom Iniciat&iacute;vy pre inova\u010dn&eacute; zdravie (IHI JU) na z&aacute;klade grantovej dohody \u010d. 101132901.<\/em> <em>Spolo\u010dn&yacute; podnik z&iacute;skava podporu z programu Eur&oacute;pskej &uacute;nie pre v&yacute;skum a inov&aacute;cie Horizon Europe a od organiz&aacute;ci&iacute; EFPIA, COCIR, MedTech Europe, Vaccines Europe a EuropaBio.<\/em> <em>Financovan&eacute; Eur&oacute;pskou &uacute;niou, s&uacute;kromn&yacute;mi \u010dlenmi a prispievaj&uacute;cimi partnermi spolo\u010dn&eacute;ho podniku IHI.<\/em> <em>Vyjadren&eacute; n&aacute;zory a stanovisk&aacute; s&uacute; v&scaron;ak len n&aacute;zormi autora (autorov) a nemusia nevyhnutne odr&aacute;\u017ea\u0165 n&aacute;zory a stanovisk&aacute; uveden&yacute;ch str&aacute;n.<\/em> <em>\u017diadna z uveden&yacute;ch str&aacute;n za ne nem&ocirc;\u017ee nies\u0165 zodpovednos\u0165.<\/em><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>LIVERAIM konzorcium pracuje na vytvoren&iacute; nov&eacute;ho<br \/>skr&iacute;ningov&eacute;ho n&aacute;stroja na ochorenia pe\u010dene<\/p>\n<p>LIVERAIM konzorcium je partnerstvo podporovan&eacute; E&Uacute;, ktor&eacute; sp&aacute;ja akademick&eacute; in&scaron;tit&uacute;cie,<br \/>neziskov&eacute; organiz&aacute;cie, diagnostick&eacute; a farmaceutick&eacute; spolo\u010dnosti so zameran&iacute;m na v&yacute;skum v oblasti<br \/>ochoren&iacute; pe\u010dene a budovanie povedomia o ich eur&oacute;pskom a celosvetovom dopade.<\/p>\n<p>Sleduj n&aacute;s na soci&aacute;lnych sie\u0165ach!<\/p>\n<p>X: @LiverAim<br \/>Linkedin: https:\/\/www.linkedin.com\/company\/liveraim<\/p>\n<div id=\"simple-translate\" class=\"simple-translate-system-theme\">&nbsp;<\/div>\n","protected":false},"author":2,"featured_media":2362,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[6],"tags":[24],"class_list":["post-2188","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pre-verejnost","tag-hepatologia"],"_links":{"self":[{"href":"https:\/\/slovhep.sk\/en\/wp-json\/wp\/v2\/posts\/2188","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/slovhep.sk\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/slovhep.sk\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/slovhep.sk\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/slovhep.sk\/en\/wp-json\/wp\/v2\/comments?post=2188"}],"version-history":[{"count":0,"href":"https:\/\/slovhep.sk\/en\/wp-json\/wp\/v2\/posts\/2188\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/slovhep.sk\/en\/wp-json\/wp\/v2\/media\/2362"}],"wp:attachment":[{"href":"https:\/\/slovhep.sk\/en\/wp-json\/wp\/v2\/media?parent=2188"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/slovhep.sk\/en\/wp-json\/wp\/v2\/categories?post=2188"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/slovhep.sk\/en\/wp-json\/wp\/v2\/tags?post=2188"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}